Top 5 Diversified Bank Stocks To Invest In 2014

There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers.

Company

July 12

Weekly Loss

FLY Leasing (NYSE: FLY  )

$14.00

19%

ClickSoftware (NASDAQ: CKSW  )

$7.19

15%

Amarin (NASDAQ: AMRN  )

$5.26

12%

SodaStream (NASDAQ: SODA  )

$59.51

12%

Kandi Technologies (NASDAQ: KNDI  )

Best New Stocks To Invest In Right Now: PowerSecure International Inc (POWR)

PowerSecure International, Inc. provides energy and smart grid solutions to electric utilities and their commercial, institutional, and industrial customers. The company?s products and services include Interactive Distributed Generation power systems, smart grid monitoring for electric utilities, peak shaving and demand response, and standby power dispatch and control products; and switchgear products and systems under the NexGear brand name. It also offers utility infrastructure products and services, including transmission and distribution system construction and maintenance under the UtilityServices brand name; engineering, regulatory consulting, and electric grid system design services under the UtilityEngineering and PowerServices brand names; LED lighting for grocery, drug, and convenience stores under the EfficientLights brand name; other LED-based lighting, including street lights; lighting and efficiency products for commercial and industrial customers under the E nergyLite brand name; and LED lighting and lighting components for OEMs and electronics manufacturers, as well as for commercial, industrial, and consumer lighting applications under the IES brand name. PowerSecure serves electric utilities, as well as commercial, institutional, and industrial customers in the United States, the Mid-Atlantic, the Midwest, and the Gulf Coast regions. The company was formerly known as Metretek Technologies, Inc. and changed its name to PowerSecure International, Inc. in August 2007. PowerSecure International, Inc. was founded in 1991 and is headquartered in Wake Forest, North Carolina.

Advisors' Opinion:

• [By Monica Gerson]

  PowerSecure International (NYSE: POWR) is estimated to post its Q4 earnings at $0.09 per share on revenue of $69.18 million.

  CNinsure (NASDAQ: CISG) is projected to post its Q4 earnings at $0.10 per share.

• [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

  PowerSecure International Inc.(POWR) said its revenue soared 57% in the fourth quarter, driven by strong gains in its energy efficiency and utility infrastructure businesses. Shares climbed 12% to $25.80 in light premarket trading.

• [By MONEYMORNING]

  A good choice here is Power Secure International Inc. (Nasdaq: POWR).

  Power Secure International is a leader in combining electricity distribution with enhanced infrastructure protections. POWR is up 43% since being introduced to Energy Inner Circle readers a little over eight months ago.

Top 5 Diversified Bank Stocks To Invest In 2014: Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. The Company is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes-protease (partnered with AbbVie, the former research-based pharmaceutical business of Abbott Laboratories), NS5A (partnered with Novartis) and nucleotide polymerase, as well as a host targeted antiviral (HTA) inhibitor class targeted against cyclophilin. ABT-450, discovered through its collaboration with AbbVie, is a protease inhibitor that has demonstrated in vitro potency against known resistant HCV mutants.

In Phase I studies, ABT-450 co-administered with ritonavir, a commonly used boosting agent to increase the blood concentrations of many protease inhibitors, was shown to be safe and well tolerated. Co-administration of ABT-450 with ritonavir, which it refers to together as ABT-450/r, has enabled once-daily dosing of ABT-450. Phase II studies have demonstrated the efficacy of ABT-450/r in patients with chronic HCV, and other interferon-free Phase II studies of ABT-450-containing regimens continue. AbbVie is developing a next-generation protease inhibitor discovered within the Enanta-AbbVie collaboration. EDP-239 is the NS5A inhibitor discovered by the Company. The Company also has a program to develop nucleotide inhibitors to HCV NS5B polymerase, which is another DAA mechanism considered to have a barrier to resistance. The Company�� Bicyclolide antibiotic product candidate is EDP-788, which it is developing for use as an intravenous drug in the hospital setting and for oral dosing in the home setting. EDP-788 is a prodrug, which means that it is inactive until it is converted in the body into an active compound. EDP-788 is! a water-soluble molecule which, when administered in preclinical models, is cleanly and rapidly converted into the active compound.

Advisors' Opinion:

• [By James Fink]

  And lastly I'll go into healthcare, which is kind of a growth cyclical type name. It's partially defensive, partially growth. I think the more growth-oriented section of healthcare would be biotech, and right now, a very promising biotech stock is Enanta Pharmaceuticals. That's a NASDAQ stock; ticker symbol (ENTA).

• [By Sean Williams]

  The next big thing in treating hepatitis-C
  The other currently experimental therapy very likely to make it onto the FDA's desk before the midpoint of 2014 is AbbVie's (NYSE: ABBV  ) direct-acting antiviral combo drug. In similar fashion to Sovaldi, this DAA-combo therapy, which includes ABT-450 from Enanta Pharmaceuticals (NASDAQ: ENTA  ) , is running six confirmatory late-stage trials on various genotypes. There are, however, two primary differences between AbbVie's DAA-combo therapy and Sovaldi.

• [By George Budwell]

  Normally, such strong efficacy results would be hailed as a major achievement. However, these results are actually less impressive than those by competing drug's developed by AbbVie (NYSE: ABBV  ) , Enanta Pharmaceuticals (NASDAQ: ENTA  ) and Gilead. Bristol-Myers' therapy also has a treatment duration double that of Gilead's drug Sovaldi for genotype 1 patients. So, while these results are impressive in their own right, the therapy's commercial prospects may be limited due to the presence of superior competitors in the market.�

Top 5 Diversified Bank Stocks To Invest In 2014: Kite Realty Group Trust (KRG)

Kite Realty Group Trust is a publicly owned real estate investment trust. The firm invests in real estate markets of the United States. It engages in ownership, operation, management, leasing, acquisition, construction, expansion, and development and redevelopment of operating retail properties, retail properties under development, operating commercial properties, parking garage, commercial property under development, parcels of land, shopping, dining, and entertainment properties. Kite Realty Group was founded in 1968 and is based in Indianapolis, Indiana.

Advisors' Opinion:

• [By Lauren Pollock]

  Kite Realty Group Trust ag(KRG)reed to merge with fellow real-estate firm Inland Diversified Real Estate Trust in a stock-for-stock deal that will create a company worth $2.1 billion. Kite Realty shares climbed 5.7% to $6.50 premarket.

Top 5 Diversified Bank Stocks To Invest In 2014: Tredegar Corporation(TG)

Tredegar Corporation, through its subsidiaries, manufactures and sells plastic films and aluminum extrusions worldwide. The company offers apertured film and nonwoven materials for use in feminine hygiene products, baby diapers, and adult incontinence products under the SoftQuilt, ComfortAire, SoftAire, and FreshFeel names; breathable, embossed, and elastic materials for use as components for baby diapers, adult incontinence products, and feminine hygiene products under the ExtraFlex, FabriFlex, StretchTab, FlexAire, and FlexFeel names; and absorbent transfer layers for baby diapers and adult incontinence products under the AquiDry and AquiSoft names. It also provides single and multi-layer surface protection films under the UltraMask and ForceField names for protecting components of flat panel displays; a line of packaging films for food packaging and industrial applications; and apertured films, breathable barrier films, and laminates that regulate fluid or vapor transmi ssion. In addition, the company offers soft-alloy aluminum extrusions primarily for building and construction, distribution, transportation, electrical, consumer durables, and machinery and equipment markets; and manufactures mill, anodized, and painted aluminum extrusions for fabricators and distributors to produce curtain walls, storefronts, windows and doors, hurricane shutters, tub and shower enclosures, heatsinks and components for light emitting diode (LED) lighting, and automotive and light truck aftermarket parts. Further, it develops and produces microstructure-based optical films for the LED and fluorescent lighting markets; and develops, owns, and operates mitigation banks. Tredegar Corporation was founded in 1988 and is headquartered in Richmond, Virginia.

Advisors' Opinion:

• [By Bryan Murphy]

  It's certainly not as big as Berry Plastics Group Inc. (NYSE:BERY). It's not even as big as Tredegar Corporation (NYSE:TG). There's one big way AEP Industries (NASDAQ:AEPI) can certainly compete head-on with BERY and TG right now, however... as an investment opportunity. Thanks to the bullish bump AEPI gave us last week, a long-standing selloff has been revered, and there's a whole lot of ground to make up.